Double maintains 3 strategies that include BBIO - BridgeBio Pharma, Inc.
Current Value
$33.821 Year Return
Current Value
$33.821 Year Return
Yahoo
PALO ALTO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on May 9, 2025, the compensation committee of BridgeBio’s board of directors approved equity grants to 36 new employees in restricted stock units for an aggregate of 101,974 shares of the Company’s common stock. One-fourth of the shares underlying each employee’s restricted stock units w
Yahoo
The study is planning to randomise around 600 asymptomatic carriers of a pathogenic TTR variant.
Yahoo
We recently published an article titled Massive Sell-Offs Just Hit These 10 Stocks Today. In this article, we are going to take a look at where BridgeBio Pharma, Inc. (NASDAQ:BBIO) stands against the other stocks. Wall Street’s main indices finished mixed on Tuesday, as investors digested the country’s latest inflation figures, which came out lower than […]
Yahoo
The average of price targets set by Wall Street analysts indicates a potential upside of 63.9% in BridgeBio Pharma (BBIO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Yahoo
- ATTRibute-CM, BridgeBio’s Phase 3 clinical trial of acoramidis in patients with ATTR-CM, achieved statistical significance in reducing the risk of ACM or first CVH versus placebo in ATTRv-CM patients (59.1% risk reduction), establishing the mechanistic hypothesis that stabilizing TTR may delay or prevent ATTRv-CM - ACT-EARLY is a registrational, randomized, double blind, placebo controlled, event driven prevention study that will enroll ~600 asymptomatic carriers of a pathogenic TTR variant. D
SeekingAlpha
The reversal was largely driven by tariff uncertainty, mixed earnings results, economic and inflation concerns, and challenges to the artificial intelligence secular growth narrative.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 49.84% | $4.85B | 0.35% |
IBB | 44.52% | $5.22B | 0.45% |
ARKG | 43.77% | $944.78M | 0.75% |
PBE | 43.37% | $214.12M | 0.58% |
FBT | 42.57% | $994.71M | 0.56% |
IWO | 41.98% | $11.36B | 0.24% |
GNOM | 41.18% | $40.65M | 0.5% |
QQQJ | 40.96% | $610.08M | 0.15% |
VBK | 40.67% | $18.33B | 0.07% |
VTWO | 40.33% | $12.07B | 0.07% |
PINK | 40.28% | $131.52M | 0.5% |
ISCG | 40.23% | $645.00M | 0.06% |
PTH | 40.21% | $96.56M | 0.6% |
IWM | 40.10% | $63.95B | 0.19% |
XHE | 39.68% | $171.93M | 0.35% |
SCHA | 39.60% | $16.91B | 0.04% |
NUSC | 39.48% | $1.14B | 0.31% |
KOMP | 39.35% | $2.20B | 0.2% |
ESML | 39.19% | $1.81B | 0.17% |
FXH | 39.14% | $891.82M | 0.62% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -30.86% | $361.41M | 1.43% |
VIXY | -26.15% | $109.64M | 0.85% |
TAIL | -26.09% | $140.49M | 0.59% |
TPMN | -13.41% | $31.54M | 0.65% |
CANE | -9.37% | $10.71M | 0.29% |
USDU | -8.50% | $173.44M | 0.5% |
UUP | -7.05% | $292.27M | 0.77% |
FXY | -6.68% | $838.61M | 0.4% |
KCCA | -6.50% | $97.18M | 0.87% |
SHYM | -5.08% | $322.93M | 0.35% |
CTA | -4.95% | $1.05B | 0.76% |
UGA | -4.35% | $73.47M | 0.97% |
PALL | -4.18% | $336.74M | 0.6% |
IVOL | -3.48% | $353.94M | 1.02% |
UNG | -2.76% | $371.83M | 1.06% |
FTSD | -2.63% | $212.46M | 0.25% |
FLMI | -2.56% | $649.76M | 0.3% |
USL | -2.16% | $41.76M | 0.85% |
OILK | -2.13% | $63.21M | 0.69% |
DBE | -2.09% | $48.48M | 0.77% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CARY | -0.15% | $347.36M | 0.8% |
PPLT | 0.25% | $1.03B | 0.6% |
DBO | 0.25% | $182.54M | 0.77% |
TBIL | 0.30% | $5.76B | 0.15% |
ULST | 0.43% | $637.77M | 0.2% |
FMHI | 0.50% | $757.44M | 0.7% |
GLDM | -0.51% | $14.42B | 0.1% |
GBIL | -0.58% | $6.17B | 0.12% |
SHYD | 0.69% | $318.05M | 0.35% |
BAR | 0.85% | $1.10B | 0.1749% |
SGOL | 0.88% | $5.06B | 0.17% |
XHLF | 0.94% | $1.46B | 0.03% |
AAAU | 0.99% | $1.47B | 0.18% |
BIL | -1.01% | $45.95B | 0.1356% |
IAU | 1.11% | $45.68B | 0.25% |
CGSM | -1.21% | $658.61M | 0.25% |
OUNZ | 1.30% | $1.64B | 0.25% |
GLD | 1.33% | $96.70B | 0.4% |
TFLO | -1.39% | $7.06B | 0.15% |
USCI | 1.43% | $230.94M | 1.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ROIV | 42.04% | $7.68B | -5.70% | 0.00% |
BPMC | 41.45% | $6.43B | -6.70% | 0.00% |
XENE | 40.67% | $2.27B | -26.70% | 0.00% |
SITE | 40.22% | $5.50B | -19.85% | 0.00% |
CYTK | 39.94% | $3.56B | -50.20% | 0.00% |
CRSP | 38.85% | $3.14B | -34.78% | 0.00% |
HXL | 38.60% | $4.35B | -25.39% | 1.18% |
OC | 38.53% | $12.12B | -17.96% | 1.79% |
CRH | 37.38% | $66.31B | +18.04% | 0.00% |
DNLI | 36.92% | $2.06B | -30.04% | 0.00% |
IMNM | 36.68% | $696.10M | -44.44% | 0.00% |
IDYA | 36.44% | $1.52B | -58.32% | 0.00% |
CRS | 36.34% | $11.47B | +109.53% | 0.35% |
DHR | 36.18% | $136.66B | -27.90% | 0.60% |
EQIX | 35.66% | $84.83B | +8.47% | 2.03% |
HPE | 35.63% | $23.15B | -1.51% | 2.95% |
RXRX | 35.59% | $1.73B | -55.31% | 0.00% |
SYRE | 35.51% | $877.54M | -61.53% | 0.00% |
SDGR | 35.43% | $1.71B | +2.01% | 0.00% |
HHH | 35.42% | $3.57B | +9.86% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EDSA | -0.04% | $14.05M | -55.75% | 0.00% |
PHYS.U | -0.08% | - | - | 0.00% |
CMP | -0.08% | $811.60M | +53.79% | 0.00% |
CYCN | -0.17% | $9.37M | +2.39% | 0.00% |
CATO | 0.19% | $54.69M | -48.22% | 12.06% |
CALM | -0.25% | $5.17B | +66.43% | 6.96% |
FDP | 0.27% | $1.57B | +33.46% | 4.14% |
GFI | -0.32% | $18.61B | +31.67% | 2.75% |
ES | 0.40% | $22.92B | +1.50% | 5.85% |
SRDX | -0.42% | $400.81M | -17.75% | 0.00% |
TKC | 0.48% | $5.49B | -3.37% | 3.28% |
WTRG | 0.48% | $10.70B | -3.17% | 3.41% |
CL | 0.51% | $72.64B | -5.18% | 2.25% |
UUU | -0.58% | $4.93M | +40.20% | 0.00% |
MVO | 0.66% | $66.70M | -38.82% | 21.64% |
EC | -0.68% | $17.50B | -29.26% | 8.78% |
CI | 0.70% | $82.51B | -8.96% | 1.84% |
GORV | 0.73% | $15.42M | -96.17% | 0.00% |
KR | -0.76% | $44.68B | +24.17% | 1.89% |
COR | 0.77% | $55.43B | +28.90% | 0.56% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -20.37% | $21.28M | -72.45% | 0.00% |
STG | -10.69% | $27.05M | -37.35% | 0.00% |
VSA | -10.21% | $7.04M | -49.24% | 0.00% |
MO | -9.94% | $97.80B | +26.35% | 6.94% |
SAVA | -7.03% | $99.03M | -90.49% | 0.00% |
FMTO | -6.80% | $45.74M | -99.96% | 0.00% |
CBOE | -6.75% | $22.95B | +20.67% | 1.12% |
BTCT | -6.48% | $25.35M | +93.08% | 0.00% |
VZ | -5.97% | $183.32B | +8.02% | 6.21% |
CME | -5.77% | $98.74B | +28.80% | 3.84% |
ED | -5.54% | $36.75B | +5.26% | 3.28% |
K | -4.70% | $28.49B | +32.17% | 2.77% |
NNE | -4.57% | $966.49M | +538.97% | 0.00% |
KNOP | -4.54% | $226.71M | +23.32% | 1.57% |
EA | -3.83% | $37.51B | +15.80% | 0.51% |
PPC | -3.79% | $11.21B | +41.54% | 0.00% |
SYPR | -3.44% | $37.69M | +21.48% | 0.00% |
T | -3.41% | $196.66B | +57.98% | 4.07% |
CMS | -3.29% | $21.21B | +12.27% | 2.97% |
FATBB | -3.11% | $50.77M | -11.65% | 9.83% |